In brief, in this study we confirmed that Gal-9 is specifically expressed in certain HBV-associated HCC patients, and positive Gal-9 expression is closely correlated with some clinicopathological features, that is, lymph node metastasis and proliferation index, and also poor prognosis. The gene discussed is LGALS9; the disease is hepatocellular carcinoma.